Showing results (631-640 of 763) with videos related to
Sort By:
Pageof 77
Journal of the American Society of Nephrology : JASN|February 1, 2014
Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndromePiero Ruggenenti, Barbara Ruggiero, Paolo Cravedi, et al.Diabetes Care|July 10, 2012
Glomerular hyperfiltration and renal disease progression in type 2 diabetesPiero Ruggenenti, Esteban L Porrini, Flavio Gaspari, et al.Kidney International Reports|October 27, 2025
Randomized Trial of Dapagliflozin in Patients With Nondiabetic Stage 4 CKDMatias Trillini, Alessandro Villa, Annalisa Perna, et al.Journal of the American Society of Nephrology : JASN|September 1, 2012
Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetesPiero Ruggenenti, Esteban Porrini, Nicola Motterlini, et al.Molecular Immunology|April 7, 2015
Atypical aHUS: State of the artCarla M Nester, Thomas Barbour, Santiago Rodriquez de Cordoba, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Performance of different prediction equations for estimating renal function in kidney transplantationFlavio Gaspari, Silvia Ferrari, Nadia Stucchi, et al.Blood|June 4, 2005
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 casesFadi Fakhouri, Jean-Paul Vernant, Agnès Veyradier, et al.Diabetes|July 7, 2018
ADAMTS13 Deficiency Shortens the Life Span of Mice With Experimental DiabetesPaola Cassis, Domenico Cerullo, Cristina Zanchi, et al.Cell Transplantation|March 5, 2021
Protective Effects of Human Nonrenal and Renal Stromal Cells and Their Conditioned Media in a Rat Model of Chronic Kidney DiseaseBarbara Imberti, Domenico Cerullo, Daniela Corna, et al.Diabetes Research and Clinical Practice|February 27, 2022
Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial)Piero Ruggenenti, Monica Cortinovis, Matias Trillini, et al.Pageof 77